Achieve Life Sciences, Inc. (ACHV): Price and Financial Metrics

Achieve Life Sciences, Inc. (ACHV): $4.71

0.03 (+0.64%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add ACHV to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#259 of 328

in industry

ACHV Price/Volume Stats

Current price $4.71 52-week high $5.98
Prev. close $4.68 52-week low $3.03
Day low $4.64 Volume 53,400
Day high $4.71 Avg. volume 139,518
50-day MA $4.67 Dividend yield N/A
200-day MA $4.67 Market Cap 161.75M

ACHV Stock Price Chart Interactive Chart >


Achieve Life Sciences, Inc. (ACHV) Company Bio


Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.


ACHV Latest News Stream


Event/Time News Detail
Loading, please wait...

ACHV Latest Social Stream


Loading social stream, please wait...

View Full ACHV Social Stream

ACHV Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!